A Safety and Efficacy Study of Two Dose Levels of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease
Clinical trial NCT01132690 · COMPLETED
Trial details
- NCT number
- NCT01132690
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2012-05-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.